Ucello Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $46M
Investors
- 9
About Ucello Therapeutics
Based in Chengdu, China and founded in 2020, Ucello Therapeutics operates as a biotechnology company engaged in the R & D and production of universal CAR-T cell therapeutic drugs. The company's core technologies include cell culture technique, gene editing and plasmid virus. Based on its universal CAR-T cell technology platform CBT-X20, the company has developed several cell therapy products for malignant tumors.
Who invested in Ucello Therapeutics
9 investors across 2 rounds
See all investors in Ucello Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ucello Therapeutics
Who invested in Ucello Therapeutics?
Ucello Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ucello Therapeutics raised?
Ucello Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ucello Therapeutics last raise money?
Ucello Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does Ucello Therapeutics do?
Based in Chengdu, China and founded in 2020, Ucello Therapeutics operates as a biotechnology company engaged in the R & D and production of universal CAR-T cell therapeutic drugs.
Where is Ucello Therapeutics headquartered?
Ucello Therapeutics is headquartered in Chengdu, China.
Which VCs invest in companies like Ucello Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Ucello Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ucello Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.